Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALPINE: AZLI for New Onset Pseudomonas in Pediatric CF
NCT01375049Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Aug 2011
- Primary completion
- May 2013
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of aztreonam in Pseudomonas aeruginosa infection, cystic fibrosis (CF), sponsored by Gilead Sciences. Started Aug 2011; status: completed.
02
Drugs
aztreonam
03
Conditions
Pseudomonas aeruginosa infectioncystic fibrosis (CF)
Beyond the preview
Go deeper on NCT01375049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01375049.